Actoplus met
Metformin, Pioglitazone
500/15mg
Actoplus met is a diabetes medication containing Metformin + Pioglitazone, available as 500/15mg tablets.
Addiction Recovery
Allergy Relief
Antibiotics
Antidepressants
Antifungals
Antiparasitics
Antivirals
Autoimmune Support
Bladder Health
Bone Health
Cholesterol Management
Diabetes Management
Digestive Health
Erectile Dysfunction
Eye Care
Hair Loss
Heart & Blood Pressure
HIV Management
Hormone Therapy
Mental Health
Neurology
Nootropics
Oncology Support
Premature Ejaculation
Respiratory Health
Skin Care
Sleep Management
Thyroid Health
Weight Management
Women's Health
2 medicines
Pioglitazone is a thiazolidinedione for type 2 diabetes that can cause fluid retention and must be avoided in heart failure, and it carries a caution around long-term bladder-cancer risk.
Metformin, Pioglitazone
500/15mg
Actoplus met is a diabetes medication containing Metformin + Pioglitazone, available as 500/15mg tablets.
Pioglitazone treats type 2 diabetes by improving how your cells respond to insulin, particularly useful for people with significant insulin resistance. It's sometimes added when other diabetes medicines alone don't keep blood sugar in range. It does not treat type 1 diabetes.
Pioglitazone activates a receptor inside fat, muscle, and liver cells (PPAR-gamma) that increases their sensitivity to insulin. Cells take up more glucose from the blood, and the liver releases less. This lowers blood sugar without pushing the pancreas to make more insulin, but the receptor also encourages the body to retain fluid, which is the source of its main risks.
Common effects include swelling in the ankles or feet, modest weight gain, headache, and muscle aches.
Stop and seek urgent medical care for any of these:
This page is educational and does not replace advice from a doctor or pharmacist who knows your health history.